Vitamin D in the management of Childhood Atopic Dermatitis (eczema)

Phase 2

Recruiting

• Conditions: Atopic Dermatitis; Inflammatory and Immune System - Allergies; Skin - Dermatological conditions

• Registration Number: ACTRN12612000570886
• Lead Sponsor: Prof Dianne Campbell

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Inclusion criteria-
Atopic dermatitis consistent with diagnostic criteria of Hanifin and Rajka.
Ages- 2 years- 16 years
Moderate-severe eczema at study entry defined as an objective SCORAD of > 15 (0-83)

Exclusion Criteria

Exclusion Criteria
Ages <2 years or >16 years
Past or current history of oral immunosuppression therapy (Cyclosporin, Azathioprine, Methotrexate)
Oral corticosteroids < 6 months prior to study
IVIg therapy< 2 years prior to study
Hypercalcaemia, Hypertension, Anticonvulsant therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified